ANGO Financial Facts

Cost of sales: 43.07M
Net sales: 88.1M
See Full Income Statement

Inventories: 58.27M
TOTAL ASSETS: 726.71M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 1/6/17 *Est. EPS Growth Rate +54.5% *Last Qtr.
Average EPS % Beat Rate +6.5% Revenue Growth Rate +5.3% *Last Qtr.
Average % Move 1-Wk after EPS +13.0% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/5/16 Q117 $0.17N/A N/A $88.1M$83.8M = Details
7/13/16 Q416 $0.19$0.16 +$0.03$93.4M$88.41M = Details
4/7/16 Q316 $0.15$0.14 +$0.01$87.4M$85.07M = Details
1/7/16 Q216 $0.14$0.14 $0.00$89.2M$88.67M = Details
10/8/15 Q116 $0.11$0.11 $0.00$83.7M$84.7M = Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details